(firstQuint)Nordic Study in Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma.

 The objective of the study is 1.

 To investigate the efficacy and safety of a high-dose methotrexate-based induction polychemotherapy regimen combined with Rituximab and intraspinal DepoCyte followed by temozolomide maintenance treatment in newly diagnosed primary central nervous system lymphoma 2.

 To assess the long term outcome concerning neurotoxicity.

 Nordic Study in Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma@highlight

The purpose of the study is to test the efficacy and tolerability of a multiagent chemotherapy treatment regimen without radiotherapy in patients with newly diagnosed lymphoma in the brain.

